Gilead press release
WebMar 29, 2024 · For more information about Gilead, please visit the company's website at www.gilead.com , follow Gilead on Twitter (@Gilead Sciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000. WebGilead will make an upfront payment of $1.25 billion to ViiV Healthcare in the first quarter of 2024 ... This is an archived press release which may not reflect current medical …
Gilead press release
Did you know?
WebGilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines. ... News and Press ... BACK TO MAIN MENU Newsroom Press Releases Media … WebJul 12, 2024 · Gilead is committed to continued scientific innovation to provide solutions for the evolving needs of people affected by HIV around the world. Through partnerships …
WebFeb 10, 2024 · Contacts. Gilead Jacquie Ross, Investors +1 (408) 656-8793 Arran Attridge, Media +1 (650) 425-8975 Galapagos Elizabeth Goodwin, Investors +1 781 460 1784 Sofie Van Gijsel, Investors +32 485 19 14 ... WebAug 7, 2024 · Pfizer Inc. (NYSE: PFE) today announced a multi-year agreement with Gilead Sciences, Inc. to manufacture and supply Gilead’s investigational antiviral remdesivir, as …
WebFeb 17, 2024 · February 03, 2024. U.S. FDA Approves Trodelvy® in Pre-treated HR+/HER2- Metastatic Breast Cancer. February 02, 2024. Gilead Sciences Announces … WebJul 21, 2024 · Gilead Sciences, Inc. (Nasdaq: GILD) today announced its upcoming contributions to the 24th International AIDS Conference (AIDS 2024). ... This press …
WebApr 13, 2024 · Continued advancement of strategic collaborations with Gilead Sciences and Sanofi: Nurix expects to continue to achieve substantial research collaboration …
Web17 hours ago · FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its first quarter 2024 financial results will be released on Thursday, April 27, 2024 after the market closes.At 4:30 p.m. Eastern Time that day, Gilead’s management will host a webcast to discuss the company’s first quarter 2024 … csnh women\u0027s healthWebApr 13, 2024 · Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its first quarter 2024 financial results will be released on Thursday, April 27, 2024 after the market … cs niagahosterWebFeb 28, 2024 · Continued advancement of strategic collaborations with Gilead Sciences and Sanofi: Nurix expects to continue to achieve substantial research collaboration milestones throughout 2024 from its collaborations with Gilead Sciences and Sanofi. * Expected timing of events throughout the press release are based on calendar year quarters. eagletruck.orgWebMar 20, 2024 · Gilead Forward-Looking Statements This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of … csn hygienicsWeb17 hours ago · FOSTER CITY, Calif., April 13, 2024--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its first quarter 2024 financial results will be released on Thursday, … cs nickleriWeb17 hours ago · FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its first quarter 2024 financial results will be released on … csni cricket twitterWebFeb 2, 2024 · Gilead directs readers to its press releases, annual reports on Form 10-K, quarterly reports on Form 10-Q and other subsequent disclosure documents filed with the SEC. Gilead claims the protection of the Safe Harbor contained in the Private Securities Litigation Reform Act of 1995 for forward-looking statements. csn ict revision